Fundraising Fox
/Companies
Sign in

Terray Therapeutics

Founded 2018 · 12 known investors

Find your way into Terray Therapeutics

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines. It develops therapeutic candidates by integrating high-throughput experimentation with machine learning.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Terray Therapeutics was founded in 2018 by Eli Berlin.

EBEli Berlin
Eli BerlinCo-Founder

Board

CPChris Picardo
Chris PicardoPartner at Madrona investing at the intersection of life science and computer science, plus consumer tech and Web3
DPDusan Perovic
Dusan PerovicPartner at Two Sigma Ventures
SSSid Shenai
Sid ShenaiVenture partner at Madrona and co-founder and CEO of Proof Diagnostics
SBSamuel Bjork
Samuel BjorkPartner at Digitalis Ventures
BD
Bassil Dahiyat, Ph.D.
WY
Wendy Young, Ph.D.

Investors · 12

Digitalis Ventureslisted by Digitalis VenturesNew York · $100K – $10M

How we know: Digitalis Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Madrona Venture Grouplisted by Madrona Venture GroupSeattle · $2M – $10M

How we know: Madrona Venture Group's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us

Summit Peak Investmentslisted by Summit Peak InvestmentsFort Worth

How we know: Summit Peak Investments's portfolio page · Not right? Tell us

AlexandriareportedPasadena

How we know: funding news · Not right? Tell us

KdT VenturesreportedAustin · $500K – $3M

How we know: the VCSheet dataset · Not right? Tell us

Mana VenturesreportedEstero

How we know: the VCSheet dataset · Not right? Tell us

NVenturesreportedSanta Clara

How we know: the VCSheet dataset · Not right? Tell us

NVIDIAreportedSanta Clara

How we know: press coverage · Not right? Tell us

Two Sigma VenturesreportedNew York · $2M – $15M

How we know: a partner's Signal profile · Not right? Tell us

What If VenturesreportedFrisco

How we know: a partner's Signal profile · Not right? Tell us

XTX MarketsreportedBristol

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$120M disclosed across 1 of 3 rounds · 2022–2024

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Raytherapeutics3 shared keywordsRay Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.

Companies competing with Terray Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Terray Therapeutics do?
Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines. It develops therapeutic candidates by integrating high-throughput experimentation with machine learning.
Who founded Terray Therapeutics?
Terray Therapeutics was founded by Eli Berlin in 2018.
Who are Terray Therapeutics's investors?
Terray Therapeutics's investors include Deviation Capital, Digitalis Ventures, Madrona Venture Group, Summit Peak Investments, Alexandria, KdT Ventures, Mana Ventures, NVentures and 4 more.
How much funding has Terray Therapeutics raised?
Terray Therapeutics has disclosed $120M raised across 1 of its 3 known rounds.